Patents by Inventor Feng He

Feng He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210135319
    Abstract: The present application relates to a battery module. The battery module includes a battery group and an insulating plate. The battery group includes a bus bar and a plurality of battery units, each battery unit includes a tab which includes a connecting segment and a bending segment. The insulating plate includes a plurality of plate assemblies, and the adjacent plate assemblies are connected through a connecting plate. There is an obtuse angle between each plate assembly and the connecting plate connected thereto. Each connecting segment passes through a guiding groove, and the bending segment and the bus bar are fixed and connected. The guiding groove can adjust the altitude of the tab as it passes through the insulating plate. The bending segment can be connected to the bus bar, then the process requirements can be met with a small space, which improves the energy density of the battery module.
    Type: Application
    Filed: January 9, 2021
    Publication date: May 6, 2021
    Inventors: Zhiyi YOU, Hua ZHANG, Feng QIN, Liangmei CHEN, Liangyi WANG, Runyong HE
  • Publication number: 20210128476
    Abstract: The invention discloses a lenalidomide gastro-retentive sustained-release tablet and a preparation method thereof. The sustained-release tablet comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of release enhancer with low bulk density, 23 wt % to 70 wt % of sustained-release material with low bulk density, and the balance of other pharmaceutically acceptable excipients, wherein the bulk density of the release enhancer ranges from 0.24 g/cm3 to 0.52 g/cm3; and the bulk density of the sustained-release material ranges from 0.29 g/cm3 to 0.51 g/cm3. The sustained-release tablet of the invention is in a floating state in a gastric environment, is not directly discharged from a stomach due to gastric emptying, has an effect of gastric retention, and is not easily discharged with substances contained in the stomach, and has a high drug bioavailability and small side effects.
    Type: Application
    Filed: September 29, 2018
    Publication date: May 6, 2021
    Applicant: DiQi Pharmaceuticals Co., Ltd.
    Inventors: Feng LIU, Huafeng LUO, Jingyu HE, Xiaofeng TAN, Shuting LAI
  • Publication number: 20210121063
    Abstract: A large field-of-view adaptive optics retinal imaging system and method with common optical path beam scanning, the system comprises: a light source module (1), an adaptive optics module (2), a beam scanning module (3), a defocus compensation module (4), a sight beacon module (6), a pupil monitoring module (7), a detection module (8), a control module (9) and an output module (10). The beam scanning module is configured in different scanning modes for carrying out different scanning imaging functions including a large field-of-view imaging function, a small field-of-view high-resolution imaging function and a large field-of-view high-resolution imaging function. The system is simple in structure, and the common optical path structure can obtain three types of retinal imaging images, which meets the requirements of different application scenarios and improves the application range of retinal imaging.
    Type: Application
    Filed: October 23, 2019
    Publication date: April 29, 2021
    Applicant: Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences
    Inventors: Guohua SHI, Yi HE, Feng GAO, Wen KONG, Lina XING, Wanyue LI, Xin ZHANG, Jing WANG
  • Publication number: 20210115046
    Abstract: Disclosed are a pyrazolo-heteroaryl derivative, a preparation method and medical use thereof. In particular, this invention relates to a new pyrazolo-heteroaryl derivative as shown in the general formula (I), a preparation method thereof and a pharmaceutical composition containing the derivative and the use thereof as a therapeutic agent, in particular as a TLR7 agonist, wherein each substituent in the general formula (I) is defined in the description.
    Type: Application
    Filed: November 27, 2017
    Publication date: April 22, 2021
    Inventors: Guobao ZHANG, Chunfeng SHU, Qiyue HU, Feng HE, Weikang TAO
  • Publication number: 20210119086
    Abstract: A light-emitting diode (LED) includes a light-transmissive substrate which has a first surface, an epitaxial structure which is disposed on the first surface, a first insulation layer, and a second insulation layer. The epitaxial structure has an upper surface opposite to the first surface, and a side wall interconnecting the upper surface and the first surface. The first insulation layer covers the side wall and the upper surface. The second insulation layer covers a portion of the first surface that is not covered by the epitaxial structure and the first insulation layer, and has a light transmittance greater than that of the first insulation layer. An LED package, an LED module, and a display device including the LEDs are also disclosed.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 22, 2021
    Inventors: Feng WANG, Zhanggen XIA, Yu ZHAN, En-song NIE, Anhe HE, Kang-Wei PENG, Su-Hui LIN
  • Publication number: 20210107827
    Abstract: A method for chemical toughening a thin glass article with a thickness of at most 0.07 mm is provided. The method includes immersing the glass article into a bath of molten salt having a certain toughening temperature for a certain toughening time to form a toughened glass article; lifting the toughened glass article out of the bath of molten salt; post-toughening dwelling the toughened glass article for a certain dwelling time at a dwelling temperature that is higher than a melting point of the bath of molten salt and lower than a transition temperature (Tg) of the toughened glass article; and cooling and cleaning the toughened glass article.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Applicant: SCHOTT Glass Technologies (Suzhou) Co. Ltd.
    Inventors: Wei XIAO, Ning DA, Feng HE, José ZIMMER
  • Patent number: 10974990
    Abstract: A method for producing an ultrathin chemically toughened glass article is provided that includes: providing an ultrathin glass sheet with a first surface and a second surface joined by at least one edge, having a thickness between the first and the second surface, chemically toughening the ultrathin glass sheet to produce an ultrathin toughened glass article. The method includes applying an edge pre-treatment to the at least one edge, preferably all edges, of the ultrathin glass sheet prior to the chemical toughening in order to reduce and/or blunt edge defects and to increase resistance to breakage of the ultrathin glass sheet during the chemical toughening.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: April 13, 2021
    Assignee: SCHOTT GLASS TECHNOLOGIES (SUZHOU) CO. LTD.
    Inventors: Ning Da, Feng He, Pengxiang Qian
  • Publication number: 20210078899
    Abstract: A chemically toughened glass article is provided that has a thickness (t) of equal to or less than 0.4 mm, a first surface, a second surface, and a compressive stress region that is defined by a compressive stress (CS) of at least 100 MPa and at least one edge connecting the first surface and the second surface. The at least one edge has at least one chamfer with a chamfer width (A) and a chamfer height (B). The chamfer has a ratio of chamfer width/chamfer height (A/B) of between 1.5-20 and the chamfer has a ratio of chamfer width/glass thickness (A/t) of at least 0.5.
    Type: Application
    Filed: November 13, 2020
    Publication date: March 18, 2021
    Applicant: SCHOTT Glass Technologies (Suzhou) Co. Ltd.
    Inventors: Ning DA, Feng HE
  • Publication number: 20210070650
    Abstract: An ultrathin chemically toughened and subsequently etched glass article is provided. The article has a thickness of less than or equal to 0.4 mm and a breakage height (given in mm) of more than 200 multiplied by the thickness (t given in mm)). Further, the article has a breakage bending radius (given in mm) of less than 100000 multiplied by the thickness (t given in mm) and divided by a surface compressive stress (in MPa) measured at a first surface.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Applicant: SCHOTT Glass Technologies (Suzhou) Co. Ltd.
    Inventors: Ning DA, Feng HE, Wie XIAO, Jiaqi MENG, Ulrich PEUCHERT, Michael DRISCH, Markus HEISS-CHOUQUET, Inge BURGER, Julia WEISSHUHN
  • Patent number: 10941067
    Abstract: A shaped glass article is provided that is ultrathin, has two surfaces and one or more edges joining the two surfaces, and a thickness between the two surfaces. The shaped ultrathin glass article has at least one curved area with a non-vanishing surface curvature with a minimal curvature radius R if no external forces are applied. A method for producing a shaped glass article is also provided that includes providing an ultrathin glass with two surfaces and one or more edges joining the two surfaces, having a thickness between the two surfaces and shaping the ultrathin glass to a shaped ultrathin glass article by forming at least one curved area having a non-vanishing surface curvature with a minimal curvature radius R if no external forces are applied to the shaped ultrathin glass article.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: March 9, 2021
    Assignee: SCHOTT GLASS TECHNOLOGIES (SUZHOU) CO. LTD.
    Inventors: Feng He, Ning Da, Pengxiang Qian
  • Publication number: 20210040073
    Abstract: An azabicyclo-substituted triazole derivative, a preparation method thereof, and an application of the same in medicine are provided. In particular, a novel azabicyclo-substituted triazole derivative represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, a use thereof as a therapeutic agent, especially as an oxytocin antagonist, and for treating or preventing a disease or disorder known or shown to have beneficial effect thereon with oxytocin being suppressed are provided. The definition of each substituent in the general formula (I) is the same as the definition in the specification.
    Type: Application
    Filed: December 27, 2017
    Publication date: February 11, 2021
    Inventors: Xin LI, Yang CHEN, Tao LIU, Feng HE, Weikang TAO
  • Publication number: 20210032253
    Abstract: Disclosed are a pyrazolo[1,5-a][1,3,5]triazine-2-amine derivative as shown in general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative and the use of same as a therapeutic agent, in particular the use thereof as an A2a receptor antagonist and the use thereof in the preparation of drugs for treating conditions or diseases improved by the inhibition of A2a receptors.
    Type: Application
    Filed: February 1, 2019
    Publication date: February 4, 2021
    Inventors: Biao LU, Bin GUI, Junzhen ZHANG, Feng HE, Weikang TAO
  • Publication number: 20210032224
    Abstract: A heteroaryl[4,3-c]pyrimidin-5-amine derivative, a preparation method therefor, and medical uses thereof are provided. Specifically, a heteroaryl[4,3-c]pyrimidin-5-amine derivative of formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and uses thereof as therapeutic agents are provided. In particular, the provided compounds can be used as Ata receptor antagonists and for treatment of conditions or symptoms that are ameliorated by inhibiting the Ata receptor. The various substituent groups in the formula (I) have the meanings as described in the specification.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 4, 2021
    Inventors: Biao LU, Shenglan WANG, Xiaodong SHEN, Feng HE, Weikang TAO
  • Publication number: 20210030035
    Abstract: The present invention relates to a natural fermented composition of pollen using glacial snow water obtained by mixing pollen, such as bee pollen, pollen, and edible flowers, with glacial snow water and fermenting same, and a preparation method therefor. In the present invention, provided is a composition obtained by mixing glacial snow water having a pH of 7.5 to 8.8 and a density of 0.05-0.85 g/cm3 with one or more kinds of pollens selected from bee pollen, pollen, flower buds, floral leaves, and floral nectaries and fermenting the mixture for three months or longer without inoculation of microorganisms. The natural fermented composition of the pollens of the present invention contains a wide variety of nutritional and active ingredients, and can exhibit various effects. Especially, since the composition has excellent antioxidative effects, the composition may be used for foods and beverages, antioxidant drinks, etc.
    Type: Application
    Filed: November 28, 2018
    Publication date: February 4, 2021
    Inventors: Byong Chul YOO, Mi Ryeong KIM, Feng He JIN
  • Patent number: 10906905
    Abstract: The present invention relates to a five-membered heteroaryl ring bridged ring derivative, a preparation method therefor and the medical use thereof. In particular, the present invention relates to a new five-membered heteroaryl ring bridged ring derivative as shown in formula (I), a preparation method therefor and a pharmaceutical composition comprising the derivative, and the use thereof as a therapeutic agent, in particular as a TGF-? inhibitor, and the use in the preparation of a drug for treating, preventing or reducing cancers mediated by the over-expression of TGF-?, wherein the definition of each substituent in the general formula (I) is the same as defined in the description.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: February 2, 2021
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Shanghai Yu, Fanglong Yang, Jingjing Yan, Xiao Wu, Feng He, Weikang Tao
  • Patent number: 10899741
    Abstract: The present invention relates to a 3,4-bipyridyl pyrazole derivative, and a preparation method therefor and a medical application thereof. Specifically, the present invention relates to a new 3,4-bipyridyl pyrazole derivative as shown in formula (I), a preparation method for the derivative, a pharmaceutical composition containing the derivative, a use of the derivative as a therapeutic agent, in particular as a TGF-? inhibitor, and a use of the derivative in the preparation of a drug which treats, prevents or reduces cancer mediated by TGF-? overexpression. The substituents in formula (I) have the same definitions as in the description.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: January 26, 2021
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Fanglong Yang, Ling Zhang, Guangyuan Shen, Feng He, Weikang Tao
  • Patent number: 10889569
    Abstract: A condensed ring group azacyclobutyl triazole derivative, a preparation method therefor and use thereof in medicine are provided. In particular, a condensed ring group azacyclobutyl triazole derivative as represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, use thereof as a therapeutic agent, in particular as an oxytocin antagonist, and for treating or preventing a disease or a condition that is known or can exhibit a beneficial effect of inhibiting oxytocin are provided. The definition for each substituent in general formula (I) is the same as that in the description.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: January 12, 2021
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Xin Li, Wei He, Bin Wang, Zhigao Zhang, Feng He, Weikang Tao
  • Publication number: 20200340975
    Abstract: The present disclosure related to a method for screening compounds having the ability to prevent, treat or reduce malodor development on body surfaces. In particular, the method screens for compounds having the ability of preventing sweat malodor development caused by malodor causing volatile acid compounds and/or malodor causing volatile sulphur compounds. The present disclosure is based on a sensitive analytical method to determine the presence of the precursors of malodor causing volatile acid compounds and/or malodor causing volatile sulphur compounds present in sweat, which are metabolised by bacteria, such as, for example, Cornebacteria or Staphylococci to malodor causing volatile acid compounds and malodor causing volatile sulphur compounds.
    Type: Application
    Filed: January 9, 2019
    Publication date: October 29, 2020
    Inventors: Xiu-Feng He, Lily Ji-Xiu Zhang
  • Publication number: 20200331963
    Abstract: The present invention provides a salt of a phenylpropionamide derivative and a preparation method therefor. The present invention specifically provides an acetate, hydrochloride, phosphate, citrate, benzoate, or fumarate of 4-amino-1-((2R,5R,8R,14R)-2-(4-aminobutyl)-8-benzyl-5-isobutyl-4,7,10-trioxo-14-phenyl-3,6,9,12-tetraazapentadecan-1-acyl)piperidine-4-carboxylic acid, and a preparation method therefor. The salt of the compound of formula (I) of the present invention has good stability, and the simple process thereof facilitates easy operation. The invention is better suited for clinical treatment.
    Type: Application
    Filed: December 5, 2018
    Publication date: October 22, 2020
    Inventors: Lin Wang, Jingquan Ye, Qiyun Shao, Jun Feng, Feng He, Xiaoli Cao, Yahui Ma
  • Patent number: 10798802
    Abstract: A lighting device (10) is disclosed comprising a light engine (12) comprising at least one solid state lighting element (11); a controller (100) for controlling a dimming level of the light engine; a wireless communication module (16) communicatively coupled to the controller for receiving a wireless dimming instruction from a wireless controller (20); and a further communication module (15) communicatively coupled to the controller for connecting to a wired communication channel and for receiving a further dimming instruction from a further controller (30) wired to the further communication module through the wired communication channel; wherein the controller is adapted to independently control the dimming level of the light engine in response to the wireless dimming instruction and the further dimming instruction.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: October 6, 2020
    Assignee: SIGNIFY HOLDINGS B.V.
    Inventors: Eric Yang, Allen Zhang, Jeremy Jiang, Dunfa Chen, Feng He, Hai Tao Liu, Zhigang Pei